JPN/816
WTO/TBT
JP Japan
  • 30 - Pharmazeutische Erzeugnisse
2024-07-26
2024-06-27

Pharmaceutical products (HS: 30)

Partial amendment to the Minimum Requirements for Biological Products Partial amendment to The Public Notice on National Release Testing.; (1 page(s), in English)

The Minimum Requirements for Biological Products will be amended as follows:

Regarding the standard for "Freeze-dried Live Attenuated Rubella Vaccine" and "Freeze-dried Live Attenuated Measles-Rubella Combined Vaccine", the requirements in case of using human diploid cells will be added.

The Public Notice on National Release Testing will be amended as follows: The criterion for "Freeze-dried Live Attenuated Rubella Vaccine" and "Freeze-dried Live Attenuated Measles-Rubella Combined Vaccine" will be partially amended.